@article{d6de41ad4f634d2484014095903a64dc,
title = "Preliminary, Real-world, Multicenter Experience with Omadacycline for Mycobacterium abscessus Infections",
abstract = "Twelve patients were treated with omadacycline (OMC) as part of a multidrug regimen for Mycobacterium abscessus. The majority of infections were of pulmonary origin (7/12; 58.3%). The median (interquartile range) duration of OMC was 6.2 (4.2-11.0) months. Clinical success occurred in 9/12 (75.0%) patients. Three patients experienced a possible adverse effect while on therapy.",
keywords = "Mycobacterium abscessus, omadacycline, rapidly growing nontuberculous mycobacteria",
author = "Taylor Morrisette and Sara Alosaimy and Philley, {Julie V.} and Carly Wadle and Catessa Howard and Webb, {Andrew J.} and Veve, {Michael P.} and Barger, {Melissa L.} and Jeannette Bouchard and Gore, {Tristan W.} and Lagnf, {Abdalhamid M.} and Iman Ansari and Carlos Mejia-Chew and Cohen, {Keira A.} and Rybak, {Michael J.}",
note = "Funding Information: This work was supported by an investigator-initiated grant from Paratek Pharmaceuticals. Publisher Copyright: {\textcopyright} 2021 The Author(s).",
year = "2021",
month = feb,
day = "1",
doi = "10.1093/ofid/ofab002",
language = "English (US)",
volume = "8",
journal = "Open Forum Infectious Diseases",
issn = "2328-8957",
publisher = "Oxford University Press",
number = "2",
}